Trials / Completed
CompletedNCT01160627
Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 720 (actual)
- Sponsor
- Odense University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
OBJECTIVE: To evaluate the efficacy of prevention of contrast induced nephropathy in patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention. DESIGN: Prospective study. SETTING: Three-center study Acute kidney injury was defined as a rise in creatinine \>25% from baseline Serum creatinine will be measured at baseline and each day for the following 3 days and at 30 days. Patients will be randomised to: 1. Standard treatment 2. Standard treatment + acetylcystein for 2 days 3. Standard treatment + Sodium bicarbonate 500 ml / followed by 100 ml/h for 5 hours 4. Standard treatment + acetylcystein for 2 days + Sodium bicarbonate 500 ml / followed by 100 ml/h for 5 hours
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Hydration | Saline hydration |
| DRUG | Acetylcysteine | Acetylcystein tablets for 2 days |
| DRUG | Sodium bicarbonate | Sodium bicarbonate 500 ml followed by 100 ml/hour for 5 hours |
| DRUG | Combined Acetylcystein and Sodium Bicarbonate | Sodium bicarbonate 500 ml followed by 100 ml/hour for 5 hours combined with acetylcystein tablets for 2 days |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2013-03-01
- Completion
- 2013-03-01
- First posted
- 2010-07-12
- Last updated
- 2013-03-22
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01160627. Inclusion in this directory is not an endorsement.